[P50-5] EGFR ex19del and ex21L858R NSCLC cells adapt different signaling network to EGFR-TKI and ramucirumab
○Zhao Hai Lu1, Tomoko Matsui2, Xueqian Gong1, Audrey Au1, Krithi Bala1, Amelie Forest1, Deli Liu1, Andrew Capen1, Hua-chen Chang1, Jack Dempsey1, Veena Coothan Kandaswamy1, Helen Won1, Sotaro Enatsu2, Anke Klippel1(1.Eli Lilly and company, Indianapolis, 2.Eli Lilly Japan k.k., Kobe, Japan)
